Transvenous pacemaker and defibrillator implantation is an expanding practice in pediatric and congenital heart disease patients, and given the finite longevity of current lead designs, lead extraction is an eventuality for a significant subset of these patients. Data on the safety and efficacy of different lead extraction techniques in this specific patient population are limited.